Calendar IDEXX Laboratories, Inc.
Stocks
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 560.88 USD | +0.53% |
|
-0.23% | -17.09% |
| 05-27 | IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2026, May-27-2026 10:55 AM | |
| 05-26 | IDEXX Laboratories Expands Fecal Antigen Testing Platform With Tapeworm Detection | MT |
Chart calendar IDEXX Laboratories, Inc.
Upcoming events on IDEXX Laboratories, Inc.
| 2026-08-13 | Analyst/Investor Day | 08:00 |
Past events on IDEXX Laboratories, Inc.
| 2026-05-12 | Présentation aux Actionnaires / Analystes | 10:00 |
| 2026-05-11 | Annual General Meeting | |
| 2026-05-05 | Earnings release - Q1 2026 | |
| 2026-05-05 | Earnings presentation | 08:30 |
| 2026-02-02 | Earnings presentation | 08:30 |
| 2026-02-02 | Earnings release - Q4 2025 | |
| 2025-11-03 | Earnings release - Q3 2025 | |
| 2025-11-03 | Earnings presentation | 08:30 |
| 2025-08-14 | Analyst/Investor Day | 08:00 |
| 2025-08-04 | Earnings release - Q2 2025 | |
| 2025-08-04 | Earnings presentation | 08:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 661 3 648 0.35% | 3 898 3 883 0.37% | 4 304 4 285 0.44% | 4 706 | 5 114 | 5 581 |
|
EBITDA Million USD | Released Forecast Spread | 1 212 1 210 0.17% | 1 225 1 287 -4.82% | 1 505 1 486 1.28% | 1 679 | 1 846 | 2 045 |
|
EBIT Million USD | Released Forecast Spread | 1 097 1 086 1.02% | 1 128 1 134 -0.51% | 1 360 1 353 0.51% | 1 520 | 1 684 | 1 881 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 061 1 049 1.19% | 1 110 1 110 -0.03% | 1 324 1 316 0.61% | 1 484 | 1 657 | 1 872 |
|
Net income Million USD | Released Forecast Spread | 845 827 2.14% | 888 875 1.46% | 1 059 1 046 1.33% | 1 169 | 1 304 | 1 462 |
|
EPS USD | Released Forecast Spread | 10,1 9,85 2.09% | 10,7 10,5 1.67% | 13,1 12,9 1.17% | 14,7 | 16,5 | 18,7 |
| Announcement Date | 05/02/24 | 03/02/25 | 02/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 976 981 -0.55% | 954 937 1.88% | 998 996 0.2% | 1 109 1 067 3.95% | 1 105 1 071 3.16% | 1 091 1 072 1.73% | 1 141 1 109 2.88% | 1 200 | 1 191 | 1 176 | 1 213 | 1 296 | 1 290 | 1 275 | 1 332 |
|
EBITDA Million USD | Released Forecast Spread | 338 319 6.11% | 295 297 -0.47% | 351 324 8.21% | 409 382 7.14% | 391 370 5.68% | 354 348 1.78% | 400 394 1.58% | 446 | 432 | 396 | 446 | 490 | 471 | 431 | 483 |
|
EBIT Million USD | Released Forecast Spread | 304 293 3.83% | 262 253 3.55% | 317 307 3.25% | 373 352 5.89% | 355 335 6.01% | 316 313 0.82% | 363 356 1.95% | 410 | 393 | 356 | 400 | 452 | 435 | 397 | 450 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 299 286 4.38% | 256 246 4.1% | 310 298 4.22% | 362 341 6.36% | 345 321 7.43% | 307 303 1.4% | 355 348 2.27% | 399 | 383 | 349 | 391 | 445 | 428 | 394 | 450 |
|
Net income Million USD | Released Forecast Spread | 233 224 4.06% | 216 199 8.46% | 243 234 3.72% | 294 268 9.55% | 275 252 8.93% | 248 235 5.48% | 278 273 2.02% | 316 | 300 | 274 | 310 | 350 | 331 | 309 | 352 |
|
EPS USD | Released Forecast Spread | 2,80 2,69 4.28% | 2,62 2,40 8.97% | 2,96 2,85 3.92% | 3,63 3,30 10.01% | 3,40 3,14 8.29% | 3,08 2,94 4.85% | 3,47 3,41 1.69% | 3,96 | 3,78 | 3,45 | 3,92 | 4,40 | 4,22 | 3,99 | 4,50 |
| Announcement Date | 31/10/24 | 03/02/25 | 01/05/25 | 04/08/25 | 03/11/25 | 02/02/26 | 05/05/26 | - | - | - | - | - | - | - | - |
Past sector events for IDEXX Laboratories, Inc.
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXX Stock
- Calendar IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
